The 2025 EU Drug Report uncovers a rapidly evolving drug landscape, fuelled by synthetic substances, tech innovation, and global instability. With rising health and security threats, the report places urgent emphasis on real-time data, early warning systems, and bold cross-sector collaboration.
Transform models the spending and revenue outcomes for three post-prohibition market scenarios in the UK, noting potential annual net benefits to the Treasury of up to £1.5 billion.
While the Australian Capital Territory (ACT) decriminalised cannabis cultivation, restrictions on seeds and possession limits mean most growers unintentionally break the law.
Nelson and Klantschnig shine a light on farmers' relationship with legally regulated markets, including critical responses to models that neglect their inclusion.
TNI, GDPO and WOLA engage with six European countries to discuss trends towards reform in cannabis policy, offering innovative solutions for legal tensions, coordination and policy development.
